Microprocessor controlled compliance monitor for eye drop medication

British Journal of Ophthalmology

Volumn 90, Issue 7, 2006, Pages 830-832

  Hermann, Manuel Marcel ^a,b   Diestelhorst, M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS;

ARTICLE; CONTAINER; DRUG MONITORING; GLAUCOMA; HUMAN; INFORMATION PROCESSING; INTRAOCULAR PRESSURE; MICROPROCESSOR; MONITOR; MONITORING; OPHTHALMOLOGY; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SENSITIVITY AND SPECIFICITY; SENSOR; TEMPERATURE;

EID: 33745663056     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.088526     Document Type: Article

References (20)

1. Leske MC, Heijl A, Hussein M, Early Manifest Glaucoma Trial Group, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56.
2. Nordstrom BL, Friedman DS, Mozaffari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005;140:598-606.
3. Schwartz GF. Compliance and persistency in glaucoma follow-up treatment. Curr Opin Ophthalmol 2005;16:114-21.
4. Ashburn FS Jr, Goldberg I, Kass MA. Compliance with ocular therapy. Surv Ophthalmol 1980;24:237-48.
5. MacKean JM, Elkington AR. Compliance with treatments of patients with chronic open-angle glaucoma. Br J Ophthalmol 1983;67:46-9.
6. Bloch S, Rosenthal AR, Friedman L, et al. Patient compliance in glaucoma. Br J Ophthalmol 1977;61:531-4.
7. Stewart WC, Konstas AG, Pfeiffer N. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocul Pharmacol Ther 2004;20:461-9.
8. Rotchford AP, Murphy KM. Compliance with timolol treatment in glaucoma. Eye 1998;12:234-6.
9. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 1995;26:233-6.
10. Tsai JC, McClure CA, Ramos SE, et al. Compliance barriers in glaucoma: a systematic classification. J Glaucoma 2003;12:393-8.
11. de Klerk E, van der Heijde D, Landewe R, et al. The compliance- questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol 2003;30:2469-75.
12. Yee RD, Hahn MP, Christensen RE. Medication monitor for ophthalmology. Am J Ophthalmol 1974;78:774-8.
13. Granstrom PA. Glaucoma patients not compliant with their drug therapy: clinical and bahavioural aspects. Br J Ophthalmol 1982;66:464-70.
14. Norell SE, Granstrom PA, Wassen R. A medication monitor and fluorescein technique designed to study medication behaviour. Acta Ophthalmol 1980;58:459-67.
15. Kass MA. Non-compliance to ocular therapy. Ann Ophthalmol 1978;10:1244-5.
16. Kass MA, Meltzer DW, Gordon M. A miniature compliance monitor for eyedrop medication. Arch Ophthalmol 1984;102:1550-4.
17. Kass MA, Meltzer DW, Gordon M, et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986;101:515-23.
18. Kass MA, Gordon M, Morlev RE Jr, et al. Compliance with topical timolol treatment. Am J Ophthalmol 1987;103:188-93.
19. Olthoff CMG, Schouten JSAG, van de Borne BW, et al. Noncompliance with ocular hypertensive treatment in patients with glaucoma or ocular hypertension. Ophthalmology 2005;112:953-61.
20. Buller AJ, Connell B, Spencer AF. Compliance: clear communication's critical. Br J Ophthalmol 2005;89:1370.